News

Breakthrough T1D, formerly JDRF (Juvenile Diabetes Research Foundation), the leading global type 1 diabetes (T1D) research ...
The aetiology of T1D is largely unknown, but it is thought that a genetic predisposition, environmental factors and distinctive metabolic changes are involved in the initiation, development and ...
Cannabis users with type 1 diabetes (T1D) can be misdiagnosed with diabetic gastroparesis on the basis of symptoms or presentation with or without gastric emptying tests; however, cannabinoid ...
An IgA anti-transglutaminase 2 (TGA-IgA) antibody cut-off of approximately 6.1 times the upper limit of normal optimised celiac disease diagnosis in children and adolescents with type 1 diabetes ...
David Weingard, chief impact officer of T1D Moonshot and founder of Cecelia Health, tells us how T1D Moonshot aims to break silos and advance type 1 diabetes prevention and treatment options by ...
The University of Bristol's Diabetes and Metabolism Research Group is conducting the T1D-DAB study to explore how age and ethnicity affect the development of Type 1 Diabetes. We know a lot about Type ...
The findings are particularly relevant as the T1D market continues to evolve. (Image Credits: Pexel) A new study has revealed that off-label use of semaglutide (Ozempic) and tirzepatide (Mounjaro ...
Many healthcare conceptions automatically bring clinical setups and treatment of physical ailments meant to be cured. For P. D. Hinduja Hospital, Type 1 Diabetes (T1D) is a change-of-pace in care ...